Związek (6S,9aS)-N-benzylo-6-((4-hydroksyfenylo)metylo)-4,7-diokso-8-((6- (3-(piperazyno-1-ylo)azetydyno-1-ylo)pirydyno-2-ylo)metylo)-2-(prop-2-en-1-ylo)-oktahydro-1H-pirazyno(2,1-c)(1,2,4)triazyno-1-karboksyamidu

• 收藏
• 分享

专利权人:

Eisai R&D Management Co., Ltd.;PRISM Pharma Co., Ltd.

发明人:

INOUE, SATOSHI,YAMAMOTO, YUJI,ISO, KENTARO

申请号：

PL14873998

公开号：

PL3088401T3

申请日:

2014.12.22

申请国别(地区):

PL

年份:

2019

代理人:

摘要：

A compound represented by formula (1) or pharmaceutically acceptable salt thereof: wherein R 1 is a C 1-6 alkyl group； R 2 and R 3 are the same or different from each other and each is a hydrogen atom or a C 1-6 alkyl group； X 2 , X 3 and X 4 are the same or different from each other and each is a hydrogen atom or a halogen atom； and X 5 is a hydrogen atom or - P(=O)(OH) 2 has a Wnt Pathway modulating activity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/